Search - tctmd.com

Displaying 841 - 860 of 960

Sort: Relevancy | Date

News Daily News

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Yael L. Maxwell

September 20, 2013

News Daily News

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Yael L. Maxwell

September 20, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Conference News ESC 2013

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Yael L. Maxwell

September 01, 2013

News Daily News

控制良好的华法林不会降低三联疗法出血风险

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

对氯吡格雷产生高血小板反应性的DES患者未出现死亡风险增高

L.A. McKeown

August 12, 2013

News Daily News

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Jason Kahn

August 05, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Daily News

对于房颤患者，在抗凝治疗的基础上联用阿司匹林会使出血风险增高

Caitlin E. Cox

July 25, 2013

News Daily News

COURAGE: 医药治疗‘跨越’是因出现更多症状而非更多硬事件

July 19, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

Presentation

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Presenter: Jochen W?hrle

July 09, 2013

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Caitlin E. Cox

June 20, 2013

News Daily News

由休克引起的死亡风险可能不会影响长期存活

L.A. McKeown

June 20, 2013

News Daily News

ROCKET AF: Heart Failure Does Not Weaken the Case for Rivaroxaban

Caitlin E. Cox

June 20, 2013

News Daily News

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

L.A. McKeown

June 20, 2013

News Daily News

Stroke After STEMI Unusual But Carries Poor Prognosis

Yael L. Maxwell

May 03, 2013

News Daily News

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Yael L. Maxwell

April 26, 2013

News Daily News

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Caitlin E. Cox

April 19, 2013

Advertisement

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

控制良好的华法林不会降低三联疗法出血风险

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

对氯吡格雷产生高血小板反应性的DES患者未出现死亡风险增高

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

对于房颤患者，在抗凝治疗的基础上联用阿司匹林会使出血风险增高

COURAGE: 医药治疗‘跨越’是因出现更多症状而非更多硬事件

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

由休克引起的死亡风险可能不会影响长期存活

ROCKET AF: Heart Failure Does Not Weaken the Case for Rivaroxaban

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

Stroke After STEMI Unusual But Carries Poor Prognosis

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content